Gallium-68 labeled LM3 PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gallium-68 labeled LM3 PET/CT, covering 2021-12-21 to 2021-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors [Phase 1, Phase 2]